State Street’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,766,733
Closed -$60.7M 3731
2014
Q4
$60.7M Sell
1,766,733
-478,125
-21% -$15.6M 0.01% 1121
2014
Q3
$67M Sell
2,244,858
-39,384
-2% -$835K 0.01% 1019
2014
Q2
$45.8M Buy
2,284,242
+392,218
+21% +$9M ﹤0.01% 1277
2014
Q1
$51.4M Buy
1,892,024
+99,429
+6% +$2.64M 0.01% 1182
2013
Q4
$37.2M Buy
1,792,595
+14,451
+0.8% +$272K ﹤0.01% 1360
2013
Q3
$32.4M Buy
1,778,144
+200,365
+13% +$3.62M ﹤0.01% 1408
2013
Q2
$26.2M Buy
+1,577,779
New +$25.2M ﹤0.01% 1473

Other funds holding AUXL

State Street's AUXL Position: Q1 2015 in Review

State Street sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,766,733 shares — an estimated $60.7M sold.

State Street first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $67M in Q3 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • State Street reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • State Street sold 1,766,733 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $60.7M.
  • State Street first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • State Street's AUXILIUM PHARAMCEUTICALS INC position peaked at $67M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on State Street's 13F filing for Q1 2015, filed 15 May 2015.